
    
      Subjects will be optical screened at baseline visit. Study comprises two in-clinic visits.
      Subjects will arrive in a fasting state and and oral glucose bolus will be administered.

      Subjects will during each of two study days be subjected to optical readings on two different
      device prototypes. During each of the study days, FGM readings, capillary blood samples and
      arterialized venous blood samples will be collected.
    
  